PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Cyclopentolate hydrochloride - Painful Ciliary Spasm
PAD Profile : Cyclopentolate hydrochloride - Painful Ciliary Spasm
Brand Names Include :
Minims
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Eye drops
- Eye drops (preservative free, unit dose)
Important Information :
Eye drops 0.5%, 1%.
Transfer to primary care may be suitable after a minimum of 2 months supply from the specialist.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 September 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network recommends the use of cyclopentolate eye drops (0.5% & 1%) for the treatment of painful ciliary spasm in blind eyes
Cyclopentolate eye drops will be considered to be BLUE (no information sheet) on the traffic light system.
Initiation will be by consultant ophthalmologists and transfer of care can be considered after a minimum of 2 months prescribing by the consultant and once the patient has shown to be benefiting from treatment.
Associated BNF Codes
11. Eye
11.05.00. Mydriatics and cycloplegics